Log in


Congratulations on being selected to present your abstract at Wound Week™ 2023! Please find information on how to prepare your poster below.

Key Dates:

  • Register for Wound Week 2023 Register Now
  • Book your hotel with the APWCA by August 30th. Book Now

    *Please note that the registration fee and hotel costs are not waived for presenters.
  • Confirm that  you will be presenting LIVE ASAP Confirm Now
  • Present your poster Friday, September 22nd, 5:30 - 6:30 pm

General Information:

  • About: Hosted by the American Professional Wound Care Association (APWCA), Wound Week 2023 provides attendees with an innovative, unparalleled educational opportunity that will feature superior content delivered by multidisciplinary faculty with clinical expertise in the field of wound healing/care. Presenting your scholarly work at the APWCA Annual meeting will showcase your knowledge and dedication to discovery in wound care in front of a prestigious audience.
  • Dimensions: Please prepare your poster to not occupy more than a single-sided 4' x 8' space.
  • Details: You will receive the placement of your poster at check-in at the Philadelphia Downtown Marriott Hotel. Please set up your poster(s) Friday morning and take the poster(s) down on Saturday afternoon. We will not mail posters back, you will be responsible for picking them up from their presentation place. Please note you will need to prepare and print your own poster. They will be pinned to a large bulletin board, we will supply tacks. Digital and electronic posters are not available at Wound Week 2023.
  • Poster numbers TBA

Selected Abstracts

Oral Presentations - (10 minutes each, 5:30 pm-6:30 pm) - General Session Room

Oral presentations will take place from 5:30-6:30pm on Friday, September 22nd in the general session room. Your presentation should be no longer than 8 minutes to allow time for Q&A. Please prepare a powerpoint/slideshow to accompany this. Oral presentations will be judged during the Oral Abstract Session. Awards will be given to the top 3 authors at the end of the session. The top 3 winners of the oral presentations will not be eligible for the poster judging and awards which will immediately follow the oral session.

1. Sharon Latimer, PhD: Pilot testing an end-of-life wound assessment tool: preliminary findings

2. William Tettelbach, MD: Dehydrated Human Amnion Chorion Membrane (DHACM) Use in Patients with Emergent Craniectomies Demonstrates Minimal Dural Adhesions at Time of Cranioplasty

3. Alisha Oropallo, MD FACS, FSVS, FAPWCA, FABWMS: Co-localization of High Bacterial Load with Regions of Pain in Venous Leg Ulcers: Imaging Informs Interventions and Validates Patient Self-Reported Pain

4. Brandon Bosque, DPM: Surgical Reconstruction of Stage 3 and 4 Pressure Injuries with ECM Technology: A Proposed Algorithm

Presented by: Abigail Chaffin, MD, FACS, CWSP, FAPWCA 

5. Suzanne J. Bakewell, PhD: In Vitro Study Evaluating Antimicrobial Effects of a Novel Combination Therapy Technology Against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa

6. Johnathan A. Niezgoda, MS, CHWS: Enhancement of Wound STO2 using a Novel Biosynthetic Glass Fiber Matrix

7. Michael Desvigne, MD, FACS, CWS, FACCWS: The Use of Aseptically Processed Meshed Reticular Acellular Dermal Matrix as a Scaffolding to Support Flap Ingrowth in Soft Tissue Reconstruction

Poster Presentations - Please prepare your poster to not occupy more than a single-sided 4' x 8' space. Authors are asked to set up their poster(s) the morning of Friday, September 22nd, and take down the poster(s) on the afternoon of Saturday, September 23rd. The APWCA will not mail posters back, you will be responsible for removing them at 1:30pm on Saturday, September 23rd All posters not removed by 3:00pm on Saturday afternoon will be discarded. You will receive the placement of your poster at check-in at the meeting. Authors are requested but not required to be by their posters from 5:30-6:30pm on Friday, September 22nd. 

Please note - these must be physical posters presented in person. There will not be electronic posters at Wound Week.

Misael Alonso, MD, FACP, CWSP, FAPWCA:

1.     Using Non-Contact Near Infrared Spectroscopy Studies To Evaluate The Effectiveness Of Hyperbaric Oxygen Therapy Using The Marx Protocol

2.     Using Near Infrared Spectroscopy To Evaluate The Treatment of Antiphospholipid Syndrome Ulcerations using Vitamin K Antagonists with Continuous Diffusion of Oxygen Therapy

Charles Andersen, MD, FACS, MAPWCA:

3.     Near-Infrared Spectroscopy with a Provocative Maneuver to detect Critical Limb Ischemia

4.     Bacterial load imaging of chronic wound bacteria supports patient adherence, empowerment and may prevent negative outcomes

5.     Strategies to improve equity in wound bacterial-infection assessments on skin of color

Ashley Jacob, BSN, RN:

6.     Multimodal imaging device for real-time bacterial load and thermal imaging: a study of synergy in clinical wound assessment workflow


Oscar Barreto, DPM, NP, FACFAS:

7.     Successful Treatment of Diabetic Foot Ulcer Using a Novel Botanical Supercharged Wound Care Hydrogel- A Case Report


Christopher Barrett, DPM, CWS:

8.     A Novel Combination Therapy Technology: Case Studies of Complete Closure of Diabetic Foot Ulcers


Gregory Bohn, MD:

9.     A New *Ovine Collagen-based Extracellular Matrix Dressing demonstrates Cost- Effectiveness in the Treatment of Venous Leg Ulcers


Abigail Chaffin, MD, FACS, CWSP, FAPWCA:

10.  Surgical Reconstruction of Stage 3 and 4 Pressure Injuries with ECM Technology:  A Proposed Algorithm


Debashish Chakravarthy, PhD:

11.  Health Economic Evaluation of Two Types of Compression Systems for Local Treatment of Venous Leg Ulcers, Leading to Conclusions, That May Have Universal Implications Irrespective of Geography.

12.  Health Economic Analysis of Two-Layer Bandage, the Dual Compression System (DCS) for Treatment of Chronic Venous Insufficiency Based on A Large Real Life Observational Study

13.  A large real life study on the use of a novel gentle silver antimicrobial barrier dressing, Technologie Lipido Colloid-Ag* in the management of wounds during the Covid 19 Pandemic

14.  What is the perfect delivery system for a hypochlorous acid based cleanser?   What does the data show? How much cleanser should one soak into the delivery system for effectiveness?


Michael Desvigne, MD, FACS, CWS, FACCWS:

15.  The Use of Aseptically Processed Meshed Reticular Acellular Dermal Matrix as a Scaffolding to Support Flap Ingrowth in Soft Tissue Reconstruction

16.  Aseptically Processed Dehydrated Allograft Placental Membrane For Limb Salvage Reconstruction

17.  Optimizing Skin Graft Success in Venous Leg Ulcers Using Aseptically Processed Dehydrated Allograft Placental Membrane

18.  Oxidized Regenerated Cellulose (ORC) with Negative Pressure Wound Therapy Use for Wound Bed Progression

19.  Use of Negative Pressure Wound Therapy With Instillation and a Novel, Single-Piece, Foam Dressing to Provide Hydromechanical Removal of Devitalized Tissue from Complex Wound

20. Using Near Infra-red Spectroscopy as a Guide for Operative Debridement Enhancing Surgical Wound Reconstruction Outcomes


21.  Management of intravenous drug abuse (IVDA) soft tissue injuries with the continuum of negative pressure wound therapy


Robert Frykberg, DPM, MPH: 

22.  Biofilm Disruption in a Diabetic Foot Ulcer with a Unique Chelating Agent

23.  Chelation: A New Dynamic in Wound Care

24.  ThermoReversible Technology Provides a Pathway to Better Wound Outcomes

25.  Technology Reduces Biofilms by 99.99999%Advanced Micelle Technology Reduces Biofilms by 99.99999%

26.  FentoniteTM Effectiveness Against Common Wound Pathogens

27.  Fentonite┬« –An Effective Antimicrobial Without Cytotoxicity Found with Zinc or Silver

28.  Treating 3rd Degree Burns on the Anterior Abdominal Wall of a Paraplegic Patient with an Advanced Thermoreversable Antiseptic Hydrogel


Sandeep Gopalakrishnan MS, PhD, MAPWCA

29. A Novel Nutraceutical Formulation Delivered Using Advanced Liposomal Delivery Accelerates Wound Healing

30. Advancing Wound Region Detection in Medical Images via YOLOv5 and UNET Models Enhanced with Google Vertex AI's AutoML

Martin Johnson, MD, MPH, FACS:

31.  The Financial Impact of a Multilayered Leukocyte, Platelet, Fibrin Patch on Management of Diabetic Foot Ulcers

32.  Novel Bioactive Glass Wound Matrix Promotes Healing in Hard-to-Heal wounds of Geriatric Patients with Multiple Comorbidities


Angel Matulevich, BSN, RN, CWON:

33.  The Implementation of Countermeasures to Reduce Non-invasive Pressure Injuries at A Small Community Hospital


Bijan Najafi:

34.  Harnessing Key Factors Affecting Diabetic Wound Healing Using a Holistic Visualization Tool'

35.  Continuous Diffusion of Oxygen Therapy for Surgically Closed Wounds in Ischemic Diabetic Foot Patients – A Pilot Randomized Controlled Trial


Jonathan Niszczak, MS OTR/L BT-C:

36.  A review on the antimicrobial effect of higher oxidation states of silver and its impact on antimicrobial activity, biofilm reduction and cost savings in burns and chronic wounds.



37.  12-week RCT Evaluating Impact of Routine Fluorescence Imaging of Bacteria on DFU Healing Rates

38.  Pseudomonas Scrub Down: Advances in Wound Imaging Objectively Confirm the Efficacy of Acetic Acid Against this Pathogen

39.  The use of collagen-alginate dressings in the treatment of patients with leg ulcers resulted in a reduction in wound size and an improvement in patients' quality of life

40.  Color Variability in Wound Images from Different Devices

Amit Rao, MD:

41.  A Comparison of Two Machine Learning Models to Predict Pre- vs Post-Debridement wounds


Thomas Serena, MD:

42.  Antimicrobial prescribing trends in 1447 outpatient wound assessments: baseline rates and impact of bacterial fluorescence imaging


Robert Skerker, MD, FAPWCA:

43.  RESTRATA. A new synthetic wound care scaffold aids healing in hard to heal wounds.

44.  CASE REPORT:  Relapsing panniculitis caused by Alpha-1 Antitrypsin Deficiency.


Karen Sudders, MS, RD:

45.  Treatment of multiple origin wounds, with a collagen dipeptide and amino acid oral nutrition intervention: a case series


William Tettelbach, MD, FACP, FIDSA, FUHM, CWS, FAPWCA:

46.  Dehydrated Human Umbilical Cord Allografts For The Treatment Of A Dog Bite Wound With Significant Tissue Loss: A Clinical Perspective

47.  Influence Of Adequate Debridement & The Concurrent Use Of Placental-Derived Allografts On Diabetic Foot Ulcers

48.  Dehydrated Human Amnion Chorion Membrane Allografts for Hard-to-Heal Wounds In The Post-Acute Care Setting

49.  Dehydrated Human Amnion Chorion Membrane (DHACM) Use in Patients With Emergent Craniectomies Demonstrates Min-imal Dural Adhesions at Time Of Cranioplasty

Nancy Trafelet:

50.  Systemic and topical antimicrobial prescribing trends in outpatient wound care: Observational multi-centric study from 1447 baseline wound assessments.

Brandon C. Hoffman, BS

51. Mentorship Matters: Empowering and Equipping Pre-Medical Students as Medical Assistants for Medical School Success Presented by Jonathan A. Niezgoda, MS, CHWS

Jonathan A Niezgoda, MS, CHWS 

52. Cannabis, Cannabinoids, and Wound Care: where there's smoke there is fire.

53. Enhancement of Wound STO2 using a Novel Biosynthetic Glass Fiber Matrix

54. Using Near Infra-red Spectroscopy to Document the Effectiveness of HBOT on an Atypical Scalp Wound.

55. Evaluation of Tissue Oxygenation using Near Infra-red Spectroscopy Following Pulsed Radiofrequency Energy

56. Evaluation of Enhanced Tissue Oxygenation and Perfusion using Near Infra-red Spectroscopy with Utilization of Novel Lower Extremity Therapeutic Vascular Device

57. Using Near Infra-red Spectroscopy to Assess Oxygenation and Perfusion in Pre-operative Triage of Surgical Procedures

Nutraceuticals and Wound Healing

Steven James Kavros DPM FACCWS, MAPWCA

58. The effects of a Copper-Iodine Complex-based wound irrigation solution on the reduction of biofilms grown on implant materials and in vivo porcine wounds

59. A Copper-Iodine Complex-based wound irrigation solution with persistent and long-lasting activity against clinically relevant pathogens: an in vitro model

Powered by Wild Apricot Membership Software